HeartSciences Inc. 8-K Summary
Business Context and Reporting Period
HeartSciences Inc. (HSCS) filed this Current Report on Form 8-K on July 25, 2025, with the earliest event reported on that date. The filing details updates regarding a Regulation A offering and a debt exchange transaction, with specific data points referenced as of July 29, 2025.
Key Financial Metrics and Capital Structure
- Regulation A Offering Proceeds: The Company has raised $4.3 million in gross proceeds to date.
- Units Issued: 1,241,188 Units have been issued under the offering.
- Debt Reduction: $1,105,000 of unsecured promissory note principal was extinguished via a debt-for-equity exchange.
- Common Stock Outstanding: 2,244,247 shares of common stock are issued and outstanding as of July 29, 2025.
- Offering Capacity: The offering allows for up to $15,000,000 in total proceeds (4,285,714 Units at $3.50 per Unit).
Note: The filing does not provide specific revenue, net income, operating cash flow, or liquidity ratios for the period.
Material Changes and Transactions
- Regulation A Issuance: Holders of 850,981 shares of Series D Preferred Stock (received as part of the Units) elected to convert them into an equal number of common shares.
- Debt Exchange: The Company exchanged $1,105,000 of debt issued in September 2024 for 301,111 shares of common stock.
- Capital Structure Impact: The combination of the preferred stock conversions and the debt exchange resulted in the current outstanding share count of 2,244,247.
Outlook, Risks, and Management Commentary
The filing confirms the ongoing execution of the Regulation A offering qualified by the SEC on March 10, 2025. The Company continues to close tranches of the offering, which consists of Series D Preferred Stock and warrants exercisable at $5.00 per share. No specific forward-looking guidance, risk factors, or unusual items beyond the described capital transactions are detailed in this specific 8-K text.
Investor Verification Checklist
- Verify the remaining capacity of the Regulation A offering ($15.0M target vs. $4.3M raised).
- Confirm the terms of the remaining unsecured promissory note balance after the $1.1M exchange.
- Review the conversion mechanics and expiration dates for the warrants included in the Units.
- Check subsequent filings for the final closing date of the Regulation A offering.